northernbook Chapter 244 I don't care what you think, I care what I think.
Chapter 244 I don't care what you think, I care what I think.
……
The most important thing is that many drugs have low profits, which dilutes the profit margins of best-selling drugs, rather than best-selling drugs having only such a small profit margin.
After deducting R&D investment, the profits of best-selling drugs are terrifying.
The sales volume is often tens or even hundreds of billions of dollars a year, but the actual cost is very low, so the profit is definitely more than 50%.
Gao Tianlong said that a special drug for lung cancer would require 3000 billion yuan in revenue to achieve 1000 billion yuan in profit, which seems a bit too fake.
How could Chen Xuan possibly accept such an explanation? This kind of data was just a bluff.
As long as the lung cancer drug can become a best-seller, AbbVie's marketing strategy will estimate that it will be able to quickly recover 1000 billion in revenue.
Moreover, given the huge market potential of lung cancer drugs, this is definitely a sure-win business.
A 1000 billion acquisition.
In Chen Xuan's opinion, it has just become a long-term steady flow.
The final profit will definitely be much greater than 1000 billion, otherwise he would not have offered this price.
"And even if we calculate based on 3000 billion in revenue, who says we can't do it?"
"To date, there are more than 30 drugs with sales exceeding $500 billion."
"Of these, AbbVie owns three and shares one with other groups, with total sales exceeding $3000 billion."
Seeing Gao Tianlong choked, Chen Xuan continued, "This new drug may not surpass AbbVie's best-selling drug, but it may also become AbbVie's third drug with a sales exceeding $500 billion."
One of the three drugs is shared with other pharmaceutical companies.
AbbVie can generate more than $3000 billion in sales with just three drugs.
You know, with the continuous development of modern medical technology, drugs are constantly being updated, and old drugs are constantly being replaced by new drugs.
In this case, these drugs can generate more than $500 billion, and there are even drug kings negotiating for $1000 billion.
This shows how crazy the sales of best-selling drugs are.
Therefore, if the lung cancer drug can become a best-selling drug, 1000 billion yuan is really not excessive at all.
Judging from the current performance of lung cancer drugs and their many indications, a sales volume of 3000 billion yuan is not a problem either.
Gao Tianlong...
Chen Xuan's words left him speechless.
I really want to refute, but every word the other party says is well-reasoned.
Of course, this is not impossible to refute. Chen Xuan used the sales of other drugs to prove it, which itself has a certain degree of exaggeration.
Chen Xuan may think that the lung cancer drug can create such a sales myth, but others may also think that this drug does not have such a large market.
However, the medicine is in his hands, and it would be difficult for others to object if they want to buy it.
If you don’t agree, you don’t have to buy it. Chen Xuan’s attitude is already very clear.
That's why Gao Tianlong didn't know how to refute.
"I believe that if I have the effective drug for lung cancer, the profit in five years will not be less than 1000 billion yuan."
"At least in the next ten years, this lung cancer drug will be irreplaceable, and it will be difficult for similar competing products to emerge."
"Of course, this is my personal opinion. If you think it's not worth it, you must have your reasons. I won't refute your point of view, nor will I force you to accept my point of view."
Chen Xuan finally said, "The product is like this. I think it's worth the price. If you think it's not, then we can cooperate next time. It doesn't mean we have to cooperate this time."
This last sentence also made his position clear.
To put it simply, no matter whether you think it is worth it or not, I think it is worth it.
To put it more simply - I don't care what you think, I care what I think.
Gao Tianlong...
This really gave him a headache.
Chen Xuan's attitude was too resolute, leaving no room for maneuver.
He was unable to bargain, and the former even wanted to leave.
In other words, as long as he does not accept this result, he can leave now without wasting both parties' time.
It was this attitude that gave him the most headaches.
He made a lot of preparations for this meeting, but found out that nothing seemed to be useful.
Faced with Chen Xuan's attitude, all negotiation methods seemed to have failed.
In shopping malls, people usually ask for exorbitant prices and pay back on the spot, but it seems that this doesn’t work here.
"Mr. Chen, it seems that there is a slight deviation in our understanding."
"I need to go back and re-evaluate, and I hope you can reconsider it."
"When the time comes, if we both have any new ideas, we can sit down and discuss them slowly."
Gao Tianlong was also prepared to try to bargain and get Chen Xuan to lower the price.
But the secretary next to him gently touched him, which made him realize instantly that the negotiations could not continue.
From the moment he entered the office, the entire rhythm of the place was controlled by Chen Xuan. He was like a puppet and was very passive throughout the whole process.
If the negotiations continue, even if we can reach some results in the end, the results will definitely not be good.
So no matter whether we can continue to discuss cooperation in the future, this negotiation should not continue, so as not to fall into the other party's rhythm. It is best to leave first.
"Okay, I'll consider it." Faced with the attitude expressed by Gao Tianlong, Chen Xuan had no intention of retaining him.
He also wanted to finish it quickly, so now that the other party had taken the initiative to leave, he naturally wanted more.
And his attitude does not suggest that he is likely to consider a revaluation unless there is a major change in the lung cancer drug, which will cause him to reconsider. Otherwise, there is basically no hope.
Faced with this attitude, Gao Tianlong completely gave up.
In the end, I could only leave with a feeling of depression.
I originally thought that since AbbVie was wealthy, the negotiations would go very smoothly and basically they could be concluded just by sitting down.
Who could refuse an offer from Ebovi, especially considering he was just a young man starting out?
But unexpectedly, the final result was a huge blow to him.
……